Bank of New York Mellon Corp

Bank

Position in NERV — Minerva Neurosciences, Inc.

CIK 1390777 NEW YORK, NY

Position in NERV

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$419,468

+$403,113 QoQ

Shares Held

75,580

+2968.6% QoQ

Ownership

0.158%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#25

of 58 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. NERV ranks #254 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,672,623	$830,842,010
2	REGN	Regeneron Pharmaceuticals, Inc.	758,492	$472,950,091
3	JAZZ	Jazz Pharmaceuticals plc	1,578,013	$380,253,782
4	ALNY	Alnylam Pharmaceuticals, Inc.	492,071	$148,128,128
5	INSM	INSMED Inc	1,312,756	$139,966,036
6	MRNA	Moderna, Inc.	1,701,675	$119,168,293
7	RVMD	Revolution Medicines, Inc.	601,056	$112,565,759
8	INCY	Incyte Corp	972,825	$110,279,435

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$419,468	75,580	+283.6%	Shares	Defined	2026-08-06
2022-03-31	$16,355	19,705	0.0%	Shares	Defined	2022-05-11
2021-12-31	$15,783	19,705	0.0%	Shares	Defined	2022-02-11
2021-09-30	$34,286	19,705	-35.9%	Shares	Defined	2021-11-18
2021-06-30	$71,356	30,757	-74.4%	Shares	Defined	2021-08-11
2021-03-31	$351,421	120,350	-1.5%	Shares	Defined	2021-05-13
2020-12-31	$285,949	122,201	+9.5%	Shares	Defined	2021-02-09
2020-09-30	$354,752	111,558	-0.7%	Shares	Defined	2020-11-12
2020-06-30	$405,589	112,352	+13.4%	Shares	Defined	2020-08-12
2020-03-31	$596,202	99,037	—	Shares	Defined	2020-05-06
No filing history on record for this holder in this stock.